Navigation Links
British Doctors on Everest Mission Get Bitter Dose

A British team of doctors attempting to conduct tests on Mt Everest,// the highest peak in the world, had to swallow a bitter dose after the Nepal government said the research was illegal.

The Centre for Aviation, Space and Extreme Environment Medicine (CASE) at the University College London had announced in 2005 that it would lead an expedition to the 8,848 m peak in 2007 to measure the amount of oxygen in their own blood on the summit as well as test how well their brains, lungs and metabolisms functioned at extreme altitude.

Led by CASE director Mike Grocott, the research was intended to find out more about the changes in the human body when it is pushed to its limits during critical illness on the basis of the changes that take place in extreme environments.

The Xtreme Everest Expedition, comprising researchers working in the fields of anaesthesia, intensive care and remote medicine, planned to set up laboratories on Mt Everest as it went higher up, with the final one at South Col, at an altitude of 8,000 m.

An offshoot of the experiment, Project Everest, aimed to recruit over 1,000 volunteers to measure their heart rates and breathing at high altitudes in order to come up with fitness programmes in the future.

The team, also including cardiovascular geneticist Hugh Montgomery, physician Sundeep Dhillon, clinician Roger McMorrow, diving expert Denny Levett and space expert Kevin Fong generated worldwide media hype when it announced its plans in 2005. However, there was one thing the doctors forgot - to take the permission of the host country.

According to Nirbhay Kumar Sharma, administrative officer of the Nepal Health Research Council, the apex body overseeing all research conducted in the country:
'"/>




Page: 1

Related medicine news :

1. Designer baby for British couple
2. British Authorities Seize Spurious Drugs
3. Collaborations planned between British Organization and Indian health care industry
4. British Healthcare Mission Explores Partnership Possibilities With Indian Healthcare Sector
5. British Women Flies to India for Treatment of Breast Cancer
6. Sharp Increase In Morning-After Pill Sales Among British Women
7. British company developing ‘Safer Cigarettes
8. British man Recovered from HIV
9. British medical education suffers shortage of bodies
10. Relief For British MS Patients: Cannabis-Based Oral Spray
11. British Scientists Doubt Delhi Doctor’s Stem Cell Claim
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/27/2017)... TX (PRWEB) , ... July 27, 2017 , ... ... and outsourced services, announces the internal promotion of Elrene Clinkscales to Vice President ... – Claims & Remittance Management, reporting to Derek Morkel, chief executive officer (CEO). ...
(Date:7/27/2017)... ... July 27, 2017 , ... Team Novo Nordisk, the world’s first all-diabetes professional ... squad as a stagiaire for the remainder of the 2017 season. One of our ... at the Tour of Utah. , “Every season we are excited to move an ...
(Date:7/26/2017)... (PRWEB) , ... July 26, 2017 , ... ... is pleased to now offer a major advancement in drug therapy for patients ... Ocrevus (pronounced Ah-creh-vus) is a novel B cell targeted therapy that has ...
(Date:7/26/2017)... ... July 26, 2017 , ... “We are dentists and we ... from San Jose, Calif., “so we invented the MAGNETIC/ LOCK BRACKETS.” , The patent-pending ... orthodontic braces. In doing so, it offers an effective alternative to traditional braces. As ...
(Date:7/26/2017)... Baton Rouge, Louisiana (PRWEB) , ... July 26, 2017 , ... ... their doctors to offer the ability for patients to schedule an appointment online in ... LocalMed directly from the Six Month Smiles provider directory will bring more Six Month ...
Breaking Medicine News(10 mins):
(Date:7/27/2017)... EXTON, Pa., July 27, 2017  West Pharmaceutical Services, ... financial results for the second-quarter 2017 and updated financial ... Second-Quarter 2017 Highlights Reported ... 2.5% over the prior-year quarter. Net sales at constant ... 2017 reported-diluted EPS was $0.51, compared to $0.60 in ...
(Date:7/26/2017)... NEW YORK , July 26, 2017 ... Annual Prix Galien USA Award ... honors, the Prix Galien Award recognizes outstanding biomedical and technology ... To qualify, each candidate must be ... the last five years and demonstrate tremendous potential to impact ...
(Date:7/24/2017)... 24, 2017  Diplomat Pharmacy, Inc. (NYSE: ... second quarter 2017 operating results on Monday, August 7, ... follow at 5:00 p.m. ET. ... a live broadcast of the conference call by dialing ... code 51641230 approximately 15 minutes prior to the call. ...
Breaking Medicine Technology: